Skip to content

Clinical trials

Terminated Phase 3 Diabetes Mellitus, Type 1 trials

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Diabetes Mellitus, Type 1 Phase: Phase 3 Status: Terminated Clear all

20 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20021
20062
20074
20084
20093
20111
20121
20131
20172
20221

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Terminated20

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Mannkind Corporation3
Novo Nordisk A/S3
Pfizer3
Diamyd Therapeutics AB2
Ixaka Ltd2
Andromeda Biotech Ltd.1
Diamyd Medical AB1
MacroGenics1
Northwestern University1
Rabin Medical Center1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Diabetes Mellitus, Type 120
Diabetes Mellitus9
Diabetes Mellitus, Type 27
Asthma3
Cardiovascular Diseases2
Chronic Limb-Threatening Ischemia2
Peripheral Arterial Disease2
Autoimmune Diseases1
Immune System Diseases1
Metabolic Diseases1

Trials

Showing 1 to 20 of 20. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.